NOVEL ANTIBACTERIAL PROTEIN BPS13 HAVING LYTIC CAPABILITY SPECIFIC TO BACILLUS STRAINS

摘要

The present invention relates to an antibacterial protein BPS13 having a lytic capability specific to Bacillus strains, and more specifically, to: a lytic protein BPS13 specific to Bacillus strains, which is characterized by having an amino acid sequence represented by SEQ ID NO:1 capable of specifically killing Bacillus strains that can infect and cause diseases in animals including humans; and a pharmaceutical composition containing, as an active ingredient, the lytic protein BPS13 specific to Bacillus strains, for treating infections caused the Bacillus strains.